Odaily Planet Daily reports that YZi Labs is reviewing the response actions taken by CEA Industries in the written consent solicitation process initiated by YZi Labs. These actions include adopting a poison pill plan and amending the company’s bylaws, aimed at thwarting and delaying shareholder rights. YZi Labs believes that the board’s purpose is to consolidate its own position, and the 2025 annual meeting has now been postponed to after the anniversary on December 17. Additionally, YZi Labs refutes CEA Industries’ statement that it has never considered an alternative token strategy, pointing out that CEO David Namdar explicitly stated at an industry conference in November 2025 that the company was considering shifting to assets like Solana. YZi Labs urges the board to avoid further operational actions and to ensure fairness in the director nomination and election process.
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to
Disclaimer.
